| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Caris Life Sciences, Inc. | Director | Common Stock | 10,270,906 | $277,105,962 | $26.98 | 09 Jan 2026 | By CLS-PF-SPE, LLC |
| Caris Life Sciences, Inc. | Director | Common Stock | 100,000 | $2,697,970 | $26.98 | 09 Jan 2026 | By Family Trust |
| Caris Life Sciences, Inc. | Director | Common Stock | 18,629 | $346,499 | $18.60 | 09 Jan 2026 | Direct |
| Caris Life Sciences, Inc. | Director | Series A Preferred Stock | 0 | 20 Jun 2025 | By CLS-PF-SPE, LLC | ||
| Caris Life Sciences, Inc. | Director | Stock Option | 0 | 09 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000123959426000003-castleman-peter-m-2026-01-09 | Caris Life Sciences, Inc. | 09 Jan 2026 | 2 | +$46,500 | 4 | Director | 13 Jan 2026, 18:37 |
| /report/000110465925060377-castleman-peter-m-2025-06-17 | Caris Life Sciences, Inc. | 17 Jun 2025 | 0 | $0 | 3 | Director | 17 Jun 2025, 21:32 |
| /report/000110465925061804-castleman-peter-m-2025-02-27 | Caris Life Sciences, Inc. | 27 Feb 2025 | 4 | $0 | 4 | Director | 23 Jun 2025, 18:31 |